OrbiMed Advisors raises $3.5bn

The New York-based healthcare investment firm has raised capital for three funds.

Fund names: OrbiMed Private Investments VIII, OrbiMed Royalty & Credit Opportunities III and OrbiMed Asia Partners IV
Amount raised: $3.5 billion
Stage of fundraising: Final close
Final close date: March 2021

OrbiMed Advisors has raised a total of $3.5 billion across three funds, OrbiMed Private Investments VIII, OrbiMed Royalty & Credit Opportunities III and OrbiMed Asia Partners IV according to a recent press release. OrbiMed Private Investments VIII has raised $1.5 billion, OrbiMed Royalty & Credit Opportunities III has raised $1.2 billion and OrbiMed Asia Partners IV has raised $800 million in commitments.

Capital raised by the vehicles will continue to invest in companies in healthcare, biotech and life sciences sectors across several regions.